Treatment |
Total Oocyte n | Pronuclear formation (%) | ||||
---|---|---|---|---|---|---|
1PN | 2PN + 2 PBs | >2PN | Total Fertilization | Non-fertilized | ||
IVF | ||||||
Control (DO-GC) | 41 | 10 (24 ± 1.2)a | 21 (51 ± 3.4)a | 8 (20 ± 5)a | 29 (71 ± 2)a | 2 (5 ± 1.3)a |
Vitrification | 62 | 16 (26 ± 3.2)a | 38 (61 ± 4.3)a | 8 (13 ± 2.8)a | 46 (75 ± 3.2)a | – |
ICSI | ||||||
Control (DO-GC) | 30 | 5 (17 ± 8)a | 10 (33 ± 4.2)b | . | 10 (33 ± 4.3)b | 15 (50 ± 1.1)b |
Vitrification | 43 | 3 (7 ± 1.9)b | 15 (35 ± 8)b | – | 15 (35 ± 8)b | 25 (58 ± 1.2)b |
PICSI | ||||||
Control (DO-GC) | 45 | 10 (22 ± 4)a | 22 (49 ± 9.9)a | – | 22 (49 ± 9.9)c | 13 (29 ± 6.2)c |
Vitrification | 40 | 8 (20 ± 3)a | 18 (45 ± 5.6)c | – | 18 (45 ± 5.6)c | 14 (35 ± 1.4)c |